{"id":585,"date":"2026-02-28T12:40:27","date_gmt":"2026-02-28T12:40:27","guid":{"rendered":"https:\/\/heartcareforyou.in\/blog\/icd-definition-clinical-context-and-cardiology-overview\/"},"modified":"2026-02-28T12:40:27","modified_gmt":"2026-02-28T12:40:27","slug":"icd-definition-clinical-context-and-cardiology-overview","status":"publish","type":"post","link":"https:\/\/heartcareforyou.in\/blog\/icd-definition-clinical-context-and-cardiology-overview\/","title":{"rendered":"ICD: Definition, Clinical Context, and Cardiology Overview"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">ICD Introduction (What it is)<\/h2>\n\n\n\n<p>An ICD is an implantable cardioverter-defibrillator.<br\/>\nIt is a cardiac device designed to detect and treat certain dangerous fast heart rhythms.<br\/>\nIt belongs to the category of implantable therapeutic devices used in electrophysiology and heart failure care.<br\/>\nIt is commonly encountered when discussing prevention of sudden cardiac death in people at higher arrhythmic risk.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Why ICD matters in cardiology (Clinical relevance)<\/h2>\n\n\n\n<p>Sudden cardiac death most often results from malignant ventricular arrhythmias, particularly ventricular tachycardia (VT) and ventricular fibrillation (VF). An ICD matters because it can recognize these rhythms and deliver therapy within seconds\u2014often before external help is available. In cardiology education, ICDs sit at the intersection of physiology (cardiac conduction), pathology (structural heart disease and channelopathies), and clinical decision-making (risk stratification and prevention strategies).<\/p>\n\n\n\n<p>ICDs also shape how clinicians think about prognosis. Many cardiac conditions carry two parallel risks: progressive pump failure (heart failure) and sudden arrhythmic death. These risks do not always move together, so an ICD is often discussed as a targeted tool for arrhythmic risk reduction rather than a treatment for the underlying disease process.<\/p>\n\n\n\n<p>From a systems perspective, ICDs influence care pathways: pre-implant evaluation, procedural planning, longitudinal follow-up (device checks), and coordination across emergency care, electrophysiology, general cardiology, and sometimes genetics. They also introduce important patient-centered considerations, including quality of life, anxiety related to shocks, and shared decision-making around goals of care\u2014especially in advanced illness where the balance of benefit and burden can vary by clinician and case.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Classification \/ types \/ variants<\/h2>\n\n\n\n<p>ICD is a device category rather than a single uniform implant. Common variants are based on where leads are placed, what pacing capabilities are included, and the clinical problem being addressed.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Transvenous ICD<\/strong><\/li>\n<li>A pulse generator is implanted under the skin (typically upper chest).<\/li>\n<li>One or more leads travel through the venous system into the heart.<\/li>\n<li>\n<p>This is the traditional design and can support both defibrillation and pacing functions.<\/p>\n<\/li>\n<li>\n<p><strong>Subcutaneous ICD (S-ICD)<\/strong><\/p>\n<\/li>\n<li>The system is implanted under the skin without a lead positioned inside the heart chambers.<\/li>\n<li>\n<p>It can deliver defibrillation shocks but typically does not provide the same range of pacing options as transvenous systems (capabilities vary by model and protocol).<\/p>\n<\/li>\n<li>\n<p><strong>Single-chamber vs dual-chamber ICD<\/strong><\/p>\n<\/li>\n<li><strong>Single-chamber<\/strong> systems commonly sense\/pace in one chamber (often the right ventricle).<\/li>\n<li>\n<p><strong>Dual-chamber<\/strong> systems include atrial and ventricular leads, which may help with rhythm discrimination in selected patients (choice varies by clinician and case).<\/p>\n<\/li>\n<li>\n<p><strong>CRT-D (cardiac resynchronization therapy with defibrillator)<\/strong><\/p>\n<\/li>\n<li>Combines an ICD with biventricular pacing (resynchronization) for selected patients with heart failure and electrical dyssynchrony.<\/li>\n<li>\n<p>The \u201cD\u201d indicates defibrillation capability; CRT-P refers to resynchronization without defibrillation.<\/p>\n<\/li>\n<li>\n<p><strong>Primary prevention vs secondary prevention ICD<\/strong><\/p>\n<\/li>\n<li><strong>Primary prevention<\/strong> aims to reduce risk before any life-threatening ventricular arrhythmia has occurred.<\/li>\n<li><strong>Secondary prevention<\/strong> follows survival from VT\/VF or resuscitated sudden cardiac arrest when a reversible cause is not clearly responsible.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Relevant anatomy &amp; physiology<\/h2>\n\n\n\n<p>Understanding ICDs starts with the heart\u2019s electrical system and how dangerous rhythms arise.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Conduction system basics<\/strong><\/li>\n<li>The sinoatrial (SA) node initiates impulses that spread through the atria.<\/li>\n<li>The atrioventricular (AV) node and His\u2013Purkinje system conduct impulses rapidly to coordinate ventricular contraction.<\/li>\n<li>\n<p>Normal conduction produces organized depolarization and effective pumping.<\/p>\n<\/li>\n<li>\n<p><strong>Why ventricles matter<\/strong><\/p>\n<\/li>\n<li>The ventricles generate systemic and pulmonary blood flow.<\/li>\n<li>\n<p>When ventricular activation becomes extremely rapid or chaotic (VT\/VF), cardiac output can fall abruptly, leading to syncope, shock, or cardiac arrest.<\/p>\n<\/li>\n<li>\n<p><strong>Structural substrates for ventricular arrhythmias<\/strong><\/p>\n<\/li>\n<li>Myocardial scar (for example after infarction) can create re-entry circuits that sustain VT.<\/li>\n<li>Dilated or hypertrophic myocardium can alter conduction pathways, repolarization, and mechanical-electrical coupling.<\/li>\n<li>\n<p>Certain inherited conditions affect ion channels, predisposing to polymorphic VT\/VF.<\/p>\n<\/li>\n<li>\n<p><strong>How an ICD interfaces with anatomy<\/strong><\/p>\n<\/li>\n<li>In transvenous systems, intracardiac leads detect electrical signals from within the heart and deliver pacing and\/or shocks.<\/li>\n<li>In subcutaneous systems, sensing and therapy occur via subcutaneous electrodes positioned to deliver a shock vector across the heart.<\/li>\n<li>The effectiveness of therapy depends on adequate sensing, appropriate arrhythmia classification, and successful energy delivery to terminate the arrhythmia.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Pathophysiology or mechanism<\/h2>\n\n\n\n<p>An ICD does not \u201cprevent\u201d all arrhythmias from occurring; it is designed to <strong>detect<\/strong> and <strong>treat<\/strong> specific rhythms when they occur.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Sensing and rhythm detection<\/strong><\/li>\n<li>The device continuously monitors cardiac electrical activity.<\/li>\n<li>\n<p>It uses programmed criteria to classify rhythms (for example, distinguishing ventricular from supraventricular tachycardias), relying on rate, onset patterns, stability, and sometimes atrial-ventricular relationships (features vary by device and programming).<\/p>\n<\/li>\n<li>\n<p><strong>Therapy options delivered by an ICD<\/strong><\/p>\n<\/li>\n<li><strong>Antitachycardia pacing (ATP):<\/strong> rapid pacing impulses intended to interrupt a re-entrant VT circuit and restore a stable rhythm without a shock (more applicable to monomorphic VT).<\/li>\n<li><strong>Cardioversion\/defibrillation shock:<\/strong> a high-energy shock delivered to depolarize a critical mass of myocardium, allowing the normal conduction system to re-establish organized rhythm.<\/li>\n<li>\n<p><strong>Bradycardia pacing:<\/strong> many ICDs also function as pacemakers to support slow heart rates, depending on the system\u2019s design.<\/p>\n<\/li>\n<li>\n<p><strong>Why these therapies work (physiologic principle)<\/strong><\/p>\n<\/li>\n<li>Re-entrant VT can sometimes be terminated by pacing that \u201ccaptures\u201d the circuit at the right timing (ATP).<\/li>\n<li>VF and unstable VT often require a shock to reset chaotic activation.<\/li>\n<li>Pacing for bradycardia supports cardiac output when intrinsic impulse generation or conduction is inadequate.<\/li>\n<\/ul>\n\n\n\n<p>Programming is not one-size-fits-all. Detection thresholds, discrimination algorithms, and therapy sequences are tailored to the patient\u2019s rhythm history, underlying disease, and clinician preferences, and they can be adjusted over time.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Clinical presentation or indications<\/h2>\n\n\n\n<p>ICDs are considered in clinical scenarios where the risk of life-threatening ventricular arrhythmias is meaningful. Typical situations include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Survival from cardiac arrest<\/strong> due to VT\/VF when no clearly reversible cause is identified or when risk remains elevated.<\/li>\n<li><strong>Sustained VT<\/strong>, especially when associated with hemodynamic compromise or when related to structural heart disease.<\/li>\n<li><strong>Cardiomyopathy with reduced systolic function<\/strong>, where arrhythmic risk may be increased even without prior VT\/VF (primary prevention context; specifics vary by guideline and patient factors).<\/li>\n<li><strong>Prior myocardial infarction with ventricular scar<\/strong> and clinically significant ventricular arrhythmias or elevated risk features (selection varies by protocol).<\/li>\n<li><strong>Inherited arrhythmia syndromes<\/strong> (channelopathies) such as conditions associated with polymorphic VT\/VF risk, particularly with concerning symptoms or family history; candidacy varies by clinician and case.<\/li>\n<li><strong>Certain congenital heart diseases<\/strong> or repaired congenital lesions with ventricular dysfunction or documented ventricular arrhythmias.<\/li>\n<li><strong>Heart failure patients who also meet criteria for resynchronization<\/strong>, where a CRT-D may be chosen in some cases.<\/li>\n<\/ul>\n\n\n\n<p>Symptoms that bring patients to attention may include syncope, palpitations, seizure-like episodes due to cerebral hypoperfusion, or resuscitated arrest. Importantly, ICD candidacy is typically determined by underlying diagnosis and risk assessment rather than symptoms alone.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Diagnostic evaluation &amp; interpretation<\/h2>\n\n\n\n<p>ICD evaluation has two broad phases: (1) determining whether a patient is an appropriate candidate and (2) interpreting device data after implantation.<\/p>\n\n\n\n<p><strong>Pre-implant evaluation (risk and diagnosis)<\/strong> commonly includes:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>History and exam<\/strong><\/li>\n<li>Prior syncope, documented arrhythmias, cardiac arrest, family history of sudden death, medication exposures, and comorbidities.<\/li>\n<li><strong>Electrocardiogram (ECG)<\/strong><\/li>\n<li>Baseline conduction, repolarization patterns, evidence of prior infarction, pre-excitation, or inherited electrical syndromes.<\/li>\n<li><strong>Echocardiography<\/strong><\/li>\n<li>Ventricular size and function, valve disease, and overall structural assessment.<\/li>\n<li><strong>Cardiac MRI or other imaging<\/strong> (when appropriate)<\/li>\n<li>Scar assessment and cardiomyopathy characterization (availability and suitability vary by patient factors).<\/li>\n<li><strong>Laboratory evaluation<\/strong><\/li>\n<li>Contributing conditions such as electrolyte disturbances, thyroid disease, or myocardial injury may be considered depending on context.<\/li>\n<li><strong>Ambulatory monitoring<\/strong><\/li>\n<li>Holter or event monitoring to document arrhythmia burden if needed.<\/li>\n<li><strong>Coronary assessment<\/strong><\/li>\n<li>If ischemia is suspected, clinicians may evaluate for reversible ischemia because treating it can alter arrhythmic risk.<\/li>\n<li><strong>Electrophysiology (EP) testing<\/strong><\/li>\n<li>Sometimes used to clarify arrhythmia mechanism or inducibility, though its role varies by protocol and clinical scenario.<\/li>\n<\/ul>\n\n\n\n<p><strong>Post-implant assessment and interpretation<\/strong> includes:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Device interrogation<\/strong><\/li>\n<li>Review of detected episodes, stored electrograms, therapies delivered (ATP or shocks), battery status, lead function, and sensing\/pacing thresholds.<\/li>\n<li><strong>Differentiating appropriate vs inappropriate therapy<\/strong><\/li>\n<li>Clinicians assess whether a treated rhythm was truly VT\/VF versus a supraventricular tachycardia or artifact\/oversensing.<\/li>\n<li><strong>Clinical correlation<\/strong><\/li>\n<li>Symptoms, precipitating triggers (fever, ischemia, medication changes), and heart failure status help interpret what the device recorded.<\/li>\n<\/ul>\n\n\n\n<p>Interpretation is inherently contextual: the same stored rhythm may have different implications depending on the patient\u2019s substrate and clinical stability.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Management overview (General approach)<\/h2>\n\n\n\n<p>ICDs are typically one component of a broader strategy to reduce arrhythmic events and manage underlying cardiovascular disease.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Address the underlying substrate<\/strong><\/li>\n<li>Guideline-directed therapy for heart failure or ischemic heart disease is often central, because remodeling, ischemia, and neurohormonal activation influence arrhythmic risk.<\/li>\n<li>\n<p>Treatment of reversible contributors (for example, ischemia, electrolyte abnormalities, pro-arrhythmic medications) is commonly considered.<\/p>\n<\/li>\n<li>\n<p><strong>Antiarrhythmic and rate-modifying medications<\/strong><\/p>\n<\/li>\n<li>Medications may be used to reduce arrhythmia frequency or slow ventricular response, potentially decreasing ICD therapies.<\/li>\n<li>\n<p>Choice of agent depends on rhythm type, ventricular function, comorbidities, and clinician judgment; the goal is often arrhythmia suppression and symptom control rather than replacing the ICD.<\/p>\n<\/li>\n<li>\n<p><strong>Catheter ablation<\/strong><\/p>\n<\/li>\n<li>In selected patients with recurrent monomorphic VT or frequent ICD therapies, ablation may reduce arrhythmia burden.<\/li>\n<li>\n<p>Ablation is generally considered an adjunct to, not a replacement for, ICD protection in patients who remain at risk.<\/p>\n<\/li>\n<li>\n<p><strong>ICD implantation (procedural role)<\/strong><\/p>\n<\/li>\n<li>Implantation involves placing the generator and lead(s), testing sensing\/therapy parameters as appropriate, and programming detection and treatment zones.<\/li>\n<li>\n<p>The ICD then provides ongoing monitoring and automatic therapy for qualifying rhythms.<\/p>\n<\/li>\n<li>\n<p><strong>Device programming and follow-up<\/strong><\/p>\n<\/li>\n<li>Programming strategies can influence inappropriate shock rates and battery longevity.<\/li>\n<li>\n<p>Follow-up commonly includes in-clinic checks and\/or remote monitoring, with adjustments based on recorded episodes and patient status.<\/p>\n<\/li>\n<li>\n<p><strong>Shared decision-making<\/strong><\/p>\n<\/li>\n<li>ICD decisions often incorporate life expectancy, comorbidities, patient goals, and the expected balance of benefit and burden.<\/li>\n<li>Discussions may also include future planning around device therapies in advanced illness, recognizing that preferences can change over time.<\/li>\n<\/ul>\n\n\n\n<p>This overview is educational; real-world management varies by clinician and case, and by local protocols.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Complications, risks, or limitations<\/h2>\n\n\n\n<p>ICD therapy is effective for many patients, but it has important risks and limitations that learners should recognize.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Procedural and early post-implant risks<\/strong><\/li>\n<li>Bleeding or hematoma at the pocket site<\/li>\n<li>Infection (pocket or systemic), which may require device removal in some cases<\/li>\n<li>Pneumothorax or hemothorax related to venous access (transvenous systems)<\/li>\n<li>Cardiac perforation or pericardial effusion (uncommon but clinically significant)<\/li>\n<li>\n<p>Pain, swelling, or wound healing issues<\/p>\n<\/li>\n<li>\n<p><strong>Device- and lead-related complications over time<\/strong><\/p>\n<\/li>\n<li>Lead fracture, insulation failure, or dislodgement (risk varies by device type and duration)<\/li>\n<li>Battery depletion requiring generator replacement<\/li>\n<li>\n<p>Sensing problems (undersensing or oversensing)<\/p>\n<\/li>\n<li>\n<p><strong>Therapy-related issues<\/strong><\/p>\n<\/li>\n<li><strong>Inappropriate shocks<\/strong> due to supraventricular tachycardias, oversensing, or artifact<\/li>\n<li><strong>Appropriate shocks<\/strong> can still be physically and emotionally distressing<\/li>\n<li>\n<p>Post-shock symptoms may include chest discomfort or transient anxiety<\/p>\n<\/li>\n<li>\n<p><strong>Limitations<\/strong><\/p>\n<\/li>\n<li>An ICD treats arrhythmias when they occur but does not cure the underlying cardiomyopathy or ischemic disease.<\/li>\n<li>It may not prevent death from progressive heart failure or non-cardiac illness.<\/li>\n<li>MRI compatibility and electromagnetic interference considerations depend on device type and local protocols.<\/li>\n<\/ul>\n\n\n\n<p>Contraindications are not purely device-based; candidacy often depends on overall prognosis, competing risks, and patient preferences, which vary by clinician and case.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Prognosis &amp; follow-up considerations<\/h2>\n\n\n\n<p>Prognosis in patients with an ICD is driven largely by the underlying heart disease, not the device alone. In many settings, an ICD can reduce the risk of sudden arrhythmic death, but it does not directly improve ventricular function or reverse structural disease. Outcomes therefore depend on factors such as cardiomyopathy severity, ischemic burden, renal function, diabetes, frailty, and adherence to broader cardiovascular care plans.<\/p>\n\n\n\n<p>Follow-up typically focuses on two parallel tracks:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Clinical follow-up<\/strong><\/li>\n<li>Heart failure status, ischemic symptoms, medication tolerance, and functional capacity.<\/li>\n<li>\n<p>Evaluation for triggers that may increase arrhythmia frequency (for example, decompensated heart failure or ischemia).<\/p>\n<\/li>\n<li>\n<p><strong>Device follow-up<\/strong><\/p>\n<\/li>\n<li>Routine interrogation to assess battery and lead integrity.<\/li>\n<li>Review of stored episodes to determine whether therapies were appropriate and whether programming changes might reduce unnecessary interventions.<\/li>\n<li>Remote monitoring is often used when available, but practices vary by center and patient factors.<\/li>\n<\/ul>\n\n\n\n<p>Patients who experience ICD therapies may undergo reassessment of arrhythmia mechanism and management strategy, including medication adjustments, evaluation for ischemia, or consideration of ablation. The intensity and interval of follow-up vary by protocol and the patient\u2019s clinical course.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">ICD Common questions (FAQ)<\/h2>\n\n\n\n<p><strong>Q: What does ICD stand for in cardiology?<\/strong><br\/>\nAn ICD is an implantable cardioverter-defibrillator. It is a small device implanted under the skin that monitors heart rhythm and can deliver therapy for certain dangerous ventricular arrhythmias. It is most often discussed in the context of sudden cardiac death prevention.<\/p>\n\n\n\n<p><strong>Q: Is an ICD the same as a pacemaker?<\/strong><br\/>\nThey are related but not identical. Many ICDs can provide pacemaker functions for slow heart rates, but the defining feature of an ICD is the ability to treat life-threatening fast ventricular rhythms with therapies such as antitachycardia pacing or shocks. A standard pacemaker typically does not deliver defibrillation shocks.<\/p>\n\n\n\n<p><strong>Q: What heart rhythms does an ICD treat?<\/strong><br\/>\nICDs are designed primarily to detect and treat ventricular tachycardia (VT) and ventricular fibrillation (VF). Depending on programming and device type, they may also record other rhythms and help clinicians interpret arrhythmia patterns. Rhythm classification is not perfect, which is why inappropriate therapies can occur.<\/p>\n\n\n\n<p><strong>Q: What does it feel like when an ICD delivers a shock?<\/strong><br\/>\nExperiences vary, but many patients describe shocks as sudden and unpleasant. Some episodes may be preceded by symptoms such as lightheadedness or palpitations, while others occur with little warning. Not all device therapies are shocks\u2014antitachycardia pacing may terminate some rhythms without a shock.<\/p>\n\n\n\n<p><strong>Q: How do clinicians decide who should get an ICD?<\/strong><br\/>\nDecisions are based on the likelihood of dangerous ventricular arrhythmias and the patient\u2019s overall clinical situation. Common considerations include prior VT\/VF or cardiac arrest, underlying cardiomyopathy, ventricular function on imaging, and the presence of inherited arrhythmia conditions. Specific criteria vary by guideline, protocol, and patient factors.<\/p>\n\n\n\n<p><strong>Q: What tests are typically done before ICD implantation?<\/strong><br\/>\nCommon pre-implant evaluation includes a history and physical exam, ECG, and echocardiography. Depending on the scenario, clinicians may add ambulatory rhythm monitoring, coronary evaluation for ischemia, cardiac MRI, laboratory testing, or electrophysiology studies. The goal is to clarify diagnosis, estimate arrhythmic risk, and identify reversible contributors.<\/p>\n\n\n\n<p><strong>Q: What are \u201cinappropriate shocks,\u201d and why do they happen?<\/strong><br\/>\nAn inappropriate shock occurs when the ICD delivers a shock for a rhythm that is not VT\/VF or when sensing is fooled by noise or oversensing. Causes can include rapid atrial fibrillation, supraventricular tachycardia, lead issues, or device sensing artifacts. Device programming and follow-up interrogation aim to reduce this risk.<\/p>\n\n\n\n<p><strong>Q: Can someone exercise or return to work with an ICD?<\/strong><br\/>\nMany people resume usual activities after recovery, but recommendations depend on the underlying heart condition, recent arrhythmias, and occupational risks. Clinicians often individualize guidance, especially for strenuous sports or safety-sensitive jobs. Return-to-activity planning typically considers both arrhythmia risk and device-related precautions.<\/p>\n\n\n\n<p><strong>Q: What does ICD follow-up involve?<\/strong><br\/>\nFollow-up typically includes periodic device interrogations to check battery status, lead performance, and any recorded arrhythmia episodes. Many systems also use remote monitoring, depending on availability and local practice. Clinical follow-up simultaneously addresses heart failure control, ischemia assessment, and medication optimization.<\/p>\n\n\n\n<p><strong>Q: Can people with an ICD get an MRI or go through security scanners?<\/strong><br\/>\nMRI eligibility depends on whether the system is labeled MRI-conditional and whether the facility has an appropriate protocol. Security systems and metal detectors can be relevant for some devices, but practical handling varies by device type and institutional guidance. In general, clinicians and device clinics provide device-specific instructions based on manufacturer and protocol.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>An ICD is an implantable cardioverter-defibrillator. It is a cardiac device designed to detect and treat certain dangerous fast heart rhythms. It belongs to the category of implantable therapeutic devices used in electrophysiology and heart failure care. It is commonly encountered when discussing prevention of sudden cardiac death in people at higher arrhythmic risk.<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-585","post","type-post","status-publish","format-standard","hentry"],"_links":{"self":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts\/585","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/comments?post=585"}],"version-history":[{"count":0,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts\/585\/revisions"}],"wp:attachment":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/media?parent=585"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/categories?post=585"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/tags?post=585"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}